Viewing Study NCT07195227


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-01-04 @ 2:03 PM
Study NCT ID: NCT07195227
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-10-02
First Post: 2025-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer
Sponsor: MedSIR
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module